Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

Dimopoulos, Meletios; Weisel, Katja; van de Donk, Niels W. C. J.; Ramasamy, Karthik; Gamberi, Barbara; Streetly, Matthew; Offidani, Massimo; Bridoux, Frank; de la Rubia, Javier; Mateos, Maria-Victoria; Ardizzoia, Antonio; Kueenburg, Elisabeth; Collins, Shona; Di Micco, Antonia; Rosettani, Barbara; Li, Yan; Bacon, Pamela; Sonneveld, Pieter

Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial

Autor(en):

Dimopoulos, Meletios; Weisel, Katja; van de Donk, Niels W. C. J.; Ramasamy, Karthik; Gamberi, Barbara; Streetly, Matthew; Offidani, Massimo; Bridoux, Frank; de la Rubia, Javier; Mateos, Maria-Victoria; Ardizzoia, Antonio; Kueenburg, Elisabeth; Collins, Shona; Di Micco, Antonia; Rosettani, Barbara; Li, Yan; Bacon, Pamela; Sonneveld, Pieter

Tübinger Autor(en):

Weisel, Katja

Erschienen in:

Journal of Clinical Oncology (2018), Bd. 36, H. 20, S. 2035-2043

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2017.76.1742

ISSN:

1527-7755